7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Telehealthcare for chronic obstructive pulmonary disease: Cochrane Review and meta-analysis.

      The British Journal of General Practice

      Ambulatory Care, methods, trends, Emergency Service, Hospital, Female, Hospitalization, statistics & numerical data, Humans, Male, Patient Satisfaction, Pulmonary Disease, Chronic Obstructive, mortality, therapy, Quality Assurance, Health Care, Quality of Life, Randomized Controlled Trials as Topic, Telemedicine, standards

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic obstructive pulmonary disease (COPD) is common. Telehealthcare, involving personalised health care over a distance, is seen as having the potential to improve care for people with COPD. To systematically review the effectiveness of telehealthcare interventions in COPD to improve clinical and process outcomes. Cochrane Systematic Review of randomised controlled trials. The study involved searching the Cochrane Airways Group Register of Trials, which is derived from the Cochrane Central Register of Controlled Trials, MEDLINE, embase, and CINAHL, as well as searching registers of ongoing and unpublished trials. Randomised controlled trials comparing a telehealthcare intervention with a control intervention in people with a clinical diagnosis of COPD were identified. The main outcomes of interest were quality of life and risk of emergency department visit, hospitalisation, and death. Two authors independently selected trials for inclusion and extracted data. Study quality was assessed using the Cochrane Collaboration's risk of bias method. Meta-analysis was undertaken using fixed effect and/or random effects modelling. Ten randomised controlled trials were included. Telehealthcare did not improve COPD quality of life: mean difference -6.57 (95% confidence interval [CI] = -13.62 to 0.48). However, there was a significant reduction in the odds ratios (ORs) of emergency department attendance (OR = 0.27; 95% CI = 0.11 to 0.66) and hospitalisation (OR = 0.46; 95% CI = 0.33 to 0.65). There was a non-significant change in the OR of death (OR = 1.05; 95% CI = 0.63 to 1.75). In COPD, telehealthcare interventions can significantly reduce the risk of emergency department attendance and hospitalisation, but has little effect on the risk of death.

          Related collections

          Author and article information

          Journal
          23211177
          3481514
          10.3399/bjgp12X658269

          Comments

          Comment on this article